ALso some insight into the next 5 products to come out of the Adapt platform for surgeries.
Surely they would have an indication of what can be made or achieved.
Neethling would know and so would the CEO. It would have been ascertained when they took over.
Dura Mater has been quiet. Ear institute has been quiet. Stem cell work quiet.
Prob better off just ignoring this stock for a few years the way it's goin
ALso some insight into the next 5 products to come out of the...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.35 |
Change
0.150(0.87%) |
Mkt cap ! $333.5M | |||
| Open | High | Low | Value | Volume |
| $17.19 | $17.39 | $16.90 | $350.7K | 20.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66 | $17.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |